These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34862703)

  • 1. 'I just thought that it was such an impossible thing': A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework.
    Lynch T; Ryan C; Cadogan CA
    Health Expect; 2022 Feb; 25(1):355-365. PubMed ID: 34862703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supporting safe and gradual reduction of long-term benzodiazepine receptor agonist use: Development of the SAFEGUARDING-BZRAs toolkit using a codesign approach.
    Lynch T; Ryan C; Bradley C; Foster D; Huff C; Hutchinson S; Lamberson N; Lynch L; Cadogan C
    Health Expect; 2022 Aug; 25(4):1904-1918. PubMed ID: 35672924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis.
    Lynch T; Ryan C; Hughes CM; Presseau J; van Allen ZM; Bradley CP; Cadogan CA
    Addiction; 2020 Sep; 115(9):1618-1639. PubMed ID: 31985127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients-A Systematic Review.
    Rasmussen AF; Poulsen SS; Oldenburg LIK; Vermehren C
    Metabolites; 2021 Apr; 11(4):. PubMed ID: 33923956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial.
    Coteur K; Van Nuland M; Schoenmakers B; Anthierens S; Van den Broeck K
    JMIR Form Res; 2023 Apr; 7():e43738. PubMed ID: 37027198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.
    Vinckenbosch FRJ; Vermeeren A; Vuurman EFPM; van der Sluiszen NNJJM; Verster JC; van de Loo AJAE; van Dijken JH; Veldstra JL; Brookhuis KA; De Waard D; Ramaekers JG
    Hum Psychopharmacol; 2021 Jul; 36(4):e2778. PubMed ID: 33547849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving adherence to multiple medications in older people in primary care: Selecting intervention components to address patient-reported barriers and facilitators.
    Patton DE; Cadogan CA; Ryan C; Francis JJ; Gormley GJ; Passmore P; Kerse N; Hughes CM
    Health Expect; 2018 Feb; 21(1):138-148. PubMed ID: 28766816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study.
    Sibille FX; Spinewine A; Zerah L; Maljean L; Schoevaerdts D; de Saint-Hubert M
    BMC Geriatr; 2022 Feb; 22(1):88. PubMed ID: 35100982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing community pharmacists' provision of medication adherence support to older adults: A mixed methods study using the Theoretical Domains Framework.
    Patton DE; Ryan C; Hughes CM
    Res Social Adm Pharm; 2021 Feb; 17(2):406-418. PubMed ID: 32217058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study.
    Coteur K; Mamouris P; Vaes B; Van Nuland M; Matheï C; Schoenmakers B
    Front Public Health; 2022; 10():1014734. PubMed ID: 36211642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for a randomized controlled trial comparing Sleepwell, EMPOWER, and treatment-as-usual for benzodiazepine receptor agonist discontinuation in older adults: the your answers when needing sleep in New Brunswick (YAWNS NB) study.
    Murphy AL; Turner JP; Rajda M; Magalhaes S; Allen KG; Gardner DM
    Explor Res Clin Soc Pharm; 2022 Sep; 7():100164. PubMed ID: 36045710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism.
    Chen TY; Winkelman JW; Mao WC; Tzeng NS; Kuo TBJ; Yang CCH; Tsai HJ; Wu CS
    J Thromb Haemost; 2020 Nov; 18(11):2878-2888. PubMed ID: 32741123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
    Evrard P; Henrard S; Foulon V; Spinewine A
    J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and facilitators to hospital pharmacists' engagement in medication safety activities: a qualitative study using the theoretical domains framework.
    Mekonnen AB; McLachlan AJ; Brien JE; Mekonnen D; Abay Z
    J Pharm Policy Pract; 2018; 11():2. PubMed ID: 29387420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the contextual factors, behaviour change techniques, barriers and facilitators of interventions to improve oral health in people with severe mental illness: A qualitative study.
    Mishu MP; Faisal MR; Macnamara A; Sabbah W; Peckham E; Newbronner L; Gilbody S; Gega L
    Front Psychiatry; 2022; 13():971328. PubMed ID: 36304558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned.
    Barry A; Lewin S; Cadogan CA
    BMC Prim Care; 2022 Jul; 23(1):175. PubMed ID: 35842593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to recommended physical activity in lower-limb osteoarthritis: protocol for a qualitative study exploring patients and physiotherapist perspectives using the theoretical domains framework and behaviour change taxonomy.
    Willett MJ; Greig C; Rogers D; Fenton S; Duda J; Rushton A
    BMJ Open; 2019 Oct; 9(10):e029199. PubMed ID: 31662360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.